Abbott Laboratories (ABT) EVP Louis Morrone reports 5,850-share sale and trust disposal
Rhea-AI Filing Summary
Abbott Laboratories executive Louis H. Morrone, Executive Vice President, reported transactions in common shares. On August 11, 2026, he sold 5,850 common shares in a non-derivative transaction at $109.83 per share, leaving 70,724 common shares held directly. On August 12, 2026, a discretionary transaction under Rule 16b-3(f) disposed of 12 indirectly held shares in a Profit Sharing Trust at $107.99 per share, leaving no shares reported under that indirect ownership.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 5,862 shares
Net Sell
2 txns
Insider
Morrone Louis H.
Role
EXECUTIVE VICE PRESIDENT
Sold
5,850 shs ($643K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Discretionary | Common shares without par value | 12 | $107.99 | $1K |
| Sale | Common shares without par value | 5,850 | $109.83 | $643K |
Holdings After Transaction:
Common shares without par value — 70,724 shares (Direct);
Common shares without par value — 0 shares (Indirect, Profit Sharing Trust)
Key Figures
Shares sold: 5,850 shares
Sale price per share: $109.83 per share
Shares following transaction: 70,724 shares
+2 more
5 metrics
Shares sold
5,850 shares
Non-derivative sale on August 11, 2026
Sale price per share
$109.83 per share
Price for 5,850-share sale on August 11, 2026
Shares following transaction
70,724 shares
Directly held common shares after August 11, 2026 sale
Discretionary transaction shares
12 shares
Discretionary transaction under Rule 16b-3(f) on August 12, 2026
Discretionary transaction price
$107.99 per share
Price for 12-share discretionary transaction via Profit Sharing Trust
Key Terms
Rule 16b-3(f), Profit Sharing Trust, non-derivative
3 terms
Rule 16b-3(f) regulatory
"A discretionary transaction under Rule 16b-3(f) disposed of 12 indirectly held shares"
Profit Sharing Trust financial
"a discretionary transaction under Rule 16b-3(f) disposed of 12 indirectly held shares in a Profit Sharing Trust"
non-derivative financial
"sold 5,850 common shares in a non-derivative transaction at $109.83 per share"
FAQ
What insider transactions did ABBOTT LABORATORIES (ABT) report for Louis H. Morrone?
ABBOTT LABORATORIES reported that Executive Vice President Louis H. Morrone sold and disposed of common shares. He sold 5,850 shares on August 11, 2026, and a Profit Sharing Trust disposed of 12 indirectly held shares on August 12, 2026.
Were Louis H. Morrone’s ABBOTT LABORATORIES (ABT) trades under a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked as an affirming plan (aff_10b5_one is false). One transaction is identified as a discretionary transaction under Rule 16b-3(f), but no Rule 10b5-1 trading plan is affirmed.
What type of ABBOTT LABORATORIES (ABT) security did Louis H. Morrone trade?
Both reported transactions involve ABBOTT LABORATORIES common shares without par value. One transaction was a sale in open market or private transaction, and the other was a discretionary transaction under Rule 16b-3(f) through a Profit Sharing Trust.
What does the discretionary ABBOTT LABORATORIES (ABT) transaction under Rule 16b-3(f) involve?
The discretionary transaction under Rule 16b-3(f) on August 12, 2026, reflects the disposition of 12 common shares held indirectly in a Profit Sharing Trust at $107.99 per share, reducing that indirect holding to zero.
AI-generated analysis. How Rhea-AI works. Not financial advice.
